Raising Seed for Healthcare Companies

Add this event to your calendar:
13/06/2017 17:30 13/06/2017 21:00 America/Toronto Raising Seed for Healthcare Companies JLABS @ Toronto , 661 University Avenue , Toronto , ON M5G 0B7 JLABS @ Toronto false DD/MM/YYYY

Raising Seed for Healthcare Companies

JLABS @ Toronto , 661 University Avenue , Toronto , ON M5G 0B7

June 13, 2017 from 17:30 PM to 21:00 PM (EST)

$10 - $35

You have a vision, great data and a well-executed pitch, but how do you get money and how do you get it from the right investor? Raising early-stage money for HealthTech and Life Science companies is never easy. How does it get done? From the lab to grants, or just straight to seed and Series A?

JLABS @ Toronto and NACO are teaming up to bring you a keynote & panel session to discuss the subtle tips and tricks of raising seed funds from early stage life science venture capital funds.

Topics will include:

  • Preparing to raise funds
  • Pre-qualifying a fund
  • Securing an introduction
  • Questions you should ask
  • Maintaining momentum

Don't miss this unique insider's look at raising life science capital. Gain the knowledge to improve your odds for funding success. Bring your questions to this interactive session!

3:30 PM | Registration Opens
4:00 PM | Key Note
4:40 PM | Panel Discussion
5:15 PM | Discussion and Q&A
5:30PM | Networking Reception
7:00PM | Program Close

Keynote Speaker:
Sam Ifergan | President and CEO, iGan Partners read bio»

[moderator] Peter van der Velden | General Managing Partner, Lumira Capital read bio»
Eva Lau | Founder, Two Small Fish Ventures read bio»
**More panelists to be announced.

Event Partner
World Discoveries

There is no cost to attend this workshop, but pre-registration is required.

JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Speakers' and Panelists' Biographies:
Sam Ifergan | Managing Partner, iGan Partners (Rowanwood Ventures)
Sam has over 20 years of entrepreneurial, technology and venture capital experience. As Managing Partner of the iGan Partners team, he is involved in the evaluation, structuring, execution, and monitoring of Rowanwood's investments. Sam has been extensively involved with several companies, often serving as CEO, particularly in the early stages of each company's development. Prior to founding iGan / Rowanwood Ventures, he co-founded several companies including Visualsonics, Tri-Link Technologies and Brighter Minds. Prior to that he was a strategy consultant with Mercer Management Consulting (now Oliver Wyman) where he advised Fortune 500 companies on corporate strategy. Sam has also held general management roles at NCR, where he led the deployment of enterprise-grade information technology systems. Sam holds an MBA from the John Molson School of Business and a Bachelor of Electrical Engineering from McGill University.
Connect with Sam:   Connect on LinkedIn

Peter van der Velden, MBA, MSc, BSc | Managing General Partner, Lumira Capital
Peter is the Managing General Partner of Lumira Capital, Canada's largest and most active dedicated healthcare venture capital investor. Peter brings to Lumira 27 years of passionate engagement in Canada's innovation ecosystem where he has participated as an operator, investor, service provider and mentor. Lumira is currently investing from two institutional venture capital funds as well as its own partners funds and has completed 18 new investments, (12 in Canada) in the past three years. Lumira's prior Fund enjoyed significant success, including two billion dollar plus exits (sale of Pharmasset to Gilead and the sale of Mako Surgical to Stryker). Peter is a very active volunteer in the communities in which he works and plays. He is a frequent lecturer at Canadian universities on themes related to venture capital, innovation and healthcare and he is on the board of a number of not-for-profits including the Canadian Venture and Private Equity Association where he is a director and the immediate past President. In 2014 Peter was appointed to the Government of Ontario's, Ontario Health Innovation Council whose mission is to enhance the adoption of Ontario based innovation by the Ontario health care system and in 2014 he travelled to India on a state visit with his Excellency the Right Honourable David Johnston, Governor General of Canada to explore opportunities for collaboration and to speak on topics related to innovation and venture capital. Peter holds degrees from the Schulich School of Business (MBA finance and policy) and Queen's University (MSc (pathology), BSc (honours life sciences)). Peter's current and recent past corporate board roles include: Milcom Ventures, Spinal Kinetics, CML Healthcare, First Aid Shot Therapy, Life Sciences Ontario, Vendorlink.ca and the Canadian Venture Capital and Private Equity Association.

Eva Lau | Founder, Two Small Fish Ventures
Eva has extensive knowledge and experience in building Internet products and online communities. Before starting Two Small Fish Ventures, she was Wattpad’s Head of Community and Content. She helped nurture and scale the Wattpad community from its infancy to become one of the largest online communities with tens of millions of monthly users around the world. Prior to Wattpad, she was Director of Product Development of Brightspark Labs, a Toronto based accelerator. During her tenure at Brightspark Labs she mentored and helped many tech startups in Toronto. Eva has a bachelor degree in Industrial Engineering from University of Toronto and an MBA from Schulich School of Business.

JLABS @ Toronto

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

Event contact

Related content